HealthRX TEMPO Review 2026

Erectile dysfunction affects roughly 1 in 3 men over 40, and HealthRX answers it with TEMPO 4-in-1, a compounded sublingual solution that stacks four active ingredients in a single 1 mL dose. What sets HealthRX apart is transparency: the four actives, the per-month unit, and every subscription and one-time price tier are published on the product page before you click anything. It ranks #5 in our comparison at 9/10 (14,185 votes).

TEMPO combines three PDE5 inhibitors, which work on blood flow, with a dopamine agonist that works on the brain's arousal pathway instead, covering four dimensions of the erectile response in one dose. HealthRX does not publish fixed milligram strengths for TEMPO, because your reviewing provider calibrates them to you after intake.

It is the same four-pathway coverage the rest of the 4-in-1 field targets. Compared with MEDVi QUAD, which swaps in PT-141 and L-Citrulline and publishes a 10–15 minute onset, TEMPO uses the classic apomorphine stack but does not state an onset figure. Against FeelGood QUAD, the two share the exact four ingredients; the difference comes down to pricing structure and whether the provider sets your dose before or after purchase.

HealthRX publishes two price ladders. Subscriptions are roughly 10% cheaper than the equivalent one-time supply at every length, which is exactly what the “save 10% today and on every refill” line describes.

Every plan includes the medication and supplies, the provider visit with unlimited follow-ups, and free expedited shipping, with no separate consultation or pharmacy fee and no insurance involved. At $88/mo on the annual cadence, TEMPO is one of the cheapest monthly commitments in the 4-in-1 category.

TEMPO is compounded by a licensed 503A pharmacy against a patient-specific prescription, so it is not FDA-reviewed as a finished product. Per the FDA, compounded drugs are not FDA-approved and the agency does not verify their safety or effectiveness. HealthRX operates as a marketplace platform holding LegitScript certification, with the clinical decision resting with an independent US-licensed clinician.

TEMPO suits men who have already tried a single-ingredient PDE5 tablet and want broader coverage, particularly the addition of apomorphine, which targets desire and arousal rather than circulation. It is also a strong fit for price-sensitive buyers who dislike quote-on-consultation pricing: every tier is published, and the annual subscription at $88/mo is among the cheaper monthly commitments in the 4-in-1 category. It is a poor fit if you want to be approved before you are charged, if you need a published onset time to plan around, or if you specifically want an FDA-approved branded tablet from your local pharmacy.